by Yvonne Tso, PharmD, MBA Every year, the Centers for Medicare & Medicaid Services (CMS) informs stakeholders of the methodological...

by Yvonne Tso, PharmD, MBA Beginning in CY 2025, a statutory requirement[1] takes effect for Part D sponsors to provide all Part D...

by Yvonne Tso, Senior VP, PharmD, MBA It has been said many times and in many ways – fraud, waste and abuse (FWA) prevention, detection...

by Yvonne Tso, Senior VP, PharmD, MBA The prescription drug program, or Part D, as we know it will have a different look and feel in...